Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Validation of CRISPR Targeting for Proliferation and Cytarabine Resistance Control Genes in the Acute Myeloid Leukemia Cell Line MOLM-13

BioTechniques(2022)10.2144/btn-2021-0089Source: DataRank Database

Validation of CRISPR Targeting for Proliferation and Cytarabine Resistance Control Genes in the Acute Myeloid Leukemia Cell Line MOLM-13 is a research paper published in BioTechniques (2022). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.00)OA: goldTopics (47)Linked Datasets (3)DataCite Reuse (3)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Nicholas Dunham ORCID,Hao Fan ORCID,Francine E. Garrett-Bakelman ORCID,Subhash Prajapati ORCID

Live enrichment

PubMed:35119307 PMC:PMC9413368 OpenAlex:https://openalex.org/W4210400094

National Institutes of Health

Grant: 5T32CA009109-43, P30 CA44579

University of Virginia

Grant: Cancer Center Trainee Grant, Double Hoo award

American Cancer Society

Grant: Institutional Research Grant

NCI NIH HHS

Grant: P30 CA044579

NCI NIH HHS

Grant: T32 CA009109

National Institutes of Health

Grant: 3P30CA044579-19S1

Cancer Center Support Grant

National Institutes of Health

Grant: 5T32CA009109-43

Cancer Research Training in Molecular Biology

FWCI

0.00

Citation Percentile

0.0%

goldLicense: cc-by-nc

journalhttps://doi.org/10.2144/btn-2021-0089

publisherhttps://doi.org/10.2144/btn-2021-0089

publisherhttps://www.tandfonline.com/doi/pdf/10.2144/btn-2021-0089

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35119307

repositoryhttps://doaj.org/article/eea737c93eee4030afede8a113d58336

Fields of Study

Acute Myeloid Leukemia ResearchCRISPR and Genetic EngineeringAdvanced biosensing and bioanalysis techniques0301 basic medicine03 medical and health sciencesCell LineCell Line, TumorCell ProliferationClustered Regularly Interspaced Short Palindromic RepeatsCytarabineHumansLeukemia, Myeloid, Acute

MeSH Terms

Cell LineCytarabineHumansLeukemia, Myeloid, AcuteCell Line, TumorCell ProliferationClustered Regularly Interspaced Short Palindromic Repeats

Keywords

Myeloid leukemiaCRISPRCytarabineCell cultureBiologyMyeloidGeneLeukemiaCell growthCancer researchGeneticsResistancep53ProliferationAcute myeloid leukemiaCdaCrispr-cas9DckMolm-13QH301-705.5Cell LineLeukemia, Myeloid, AcuteCell Line, TumorHumansClustered Regularly Interspaced Short Palindromic RepeatsBiology (General)Letter to the EditorCell Proliferation

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Supplementary Materials: Validation of CRISPR targeting for proliferation and cytarabine resistance control genes in the AML cell line MOLM-13

10.25402/btn.19122146.v1Taylor & Francis

Supplementary Materials: Validation of CRISPR targeting for proliferation and cytarabine resistance control genes in the AML cell line MOLM-13

10.25402/btn.19122146.v2Taylor & Francis

Supplementary Materials: Validation of CRISPR targeting for proliferation and cytarabine resistance control genes in the AML cell line MOLM-13

10.25402/btn.19122146Taylor & Francis